Protocols of Actinomycetes: Microbiology to Gene editing | Agenda Bookshop Skip to content
Selected Colleen Hoover Books at €9.99c | In-store & Online
Selected Colleen Hoover Books at €9.99c | In-store & Online
Age Group_Uncategorized
Age Group_Uncategorized
automatic-update
B01=L Karthik
Category1=Non-Fiction
Category=MB
Category=PNN
Category=PSD
Category=PST
Category=TCB
Category=TDCW
Category=TQ
Category=TVB
COP=United Kingdom
Delivery_Pre-order
Language_English
PA=Not yet available
Price_€100 and above
PS=Forthcoming
softlaunch

Protocols of Actinomycetes: Microbiology to Gene editing

English

Many of the natural products have been isolated and characterized from the actinobacteria, for example ployketides, phenazines, peptides, indolocarbarbazoles, and sterols. To explore new antibiotics from actinobacteria, several bioinformatics and synthetic biology tools were developed. This book covers basics to recent protocols for drug discovery from actinobacteria.

Features:

1. Discusses the benefits of production of antibiotics and enzymes from actinomycetes in a large scale.
2. Covers the synthetic biology approach.
3. Describes the strain improvement of actinobacteria.
4. Gives information on basic isolation of actinobacteria and modern techniques.
5. Covers the applications and metabolic engineering strategies of actinomycetes.

This book will be helpful for the pharmaceutical industries and researchers to develop new antibiotics from actinobacteria and would be used in support of future research in drug discovery.

See more
Current price €117.79
Original price €123.99
Save 5%
Age Group_Uncategorizedautomatic-updateB01=L KarthikCategory1=Non-FictionCategory=MBCategory=PNNCategory=PSDCategory=PSTCategory=TCBCategory=TDCWCategory=TQCategory=TVBCOP=United KingdomDelivery_Pre-orderLanguage_EnglishPA=Not yet availablePrice_€100 and abovePS=Forthcomingsoftlaunch

Will deliver when available. Publication date 29 Nov 2024

Product Details
  • Dimensions: 178 x 254mm
  • Publication Date: 29 Nov 2024
  • Publisher: Taylor & Francis Ltd
  • Publication City/Country: United Kingdom
  • Language: English
  • ISBN13: 9781032504230

About

L. Karthik has an extensive expertise in Actinobacteria Synthetic biology and Drug Discovery Strategies and is presently working as a Project Leader Synthetic Biology at Salem Microbes Pvt. Ltd Salem India. He is Top 2% of all scientists in the world (the Stanford University report published by Elsevier on 10th October 2022&2023).He is an elected Fellow member of Linnean Society of London. He did first postdoctoral training at the Shanghai Jiao Tong University China under the guidance of eminent scientist Prof. Zhiyong Li. Further he has completed his second postdoctoral fellowship in ECUST Shanghai China under the guidance of eminent scientist Prof. Lixin Zhang. He received his Ph.D. degree in Microbiology from the VIT University in 2013. He has published around 75 research papers (h index-26) 5 Books and 6 patents and 6 products commercialized.He is a communication committee member of International Chemical Biology Society USA and President of Society of Chemical and Synthetic biology India. In 2016 he got Prestigious Young Scientist Award from Indian Association of Applied Microbiologists for his outstanding research work. and got Best Research scholar award-2012 from VIT University. He got 200 young scientist-2012 fellowship (DST) to attend international conference. He got Best VIT ALUMNI AWARD-2022 from VIT University TN India. He is Associate Editor of Frontiers in Microbiology and Review editor of Frontiers in Marine Science and also Associate Editor of Current Chinese Engineering Science Journal (Bentham Science). Recently he proved COVID-19 activity of Kabasura Kudineer (Siddha Herbal formulation). During COVID-19 wave this drug saved lot of life. For this contribution he got COVID warrior award from SEED Trust TN India.

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)
We use cookies to ensure that we give you the best experience on our website. If you continue we'll assume that you are understand this. Learn more
Accept